Sunday, August 31, 2014

As FDA Decision Loomed For Suvorexant, Chemists Discussed Sleep Drug Field’s Big Questions

ACS Meeting News: Symposium addressed selectivity, dosing of orexin receptor antagonists



via Chemical & Engineering News: Biological SCENE http://ift.tt/1vCnOeM
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)